Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Health, social, and economic consequences of rapid eye movement sleep behavior disorder: A Controlled National Study Evaluating Societal Effects

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. Cortical Arousal Frequency is Increased in Narcolepsy Type 1

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Cerebral blood flow, oxygen metabolism, and lactate during hypoxia in patients with obstructive sleep apnea

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Nocturnal eye movements in patients with idiopathic rapid eye movement sleep behaviour disorder and patients with Parkinson's disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. A genome-wide meta-analysis yields 46 new loci associating with biomarkers of iron homeostasis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Imagery rehearsal therapy and/or mianserin in treatment of refugees diagnosed with PTSD: Results from a randomized controlled trial

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Automatic sleep stage classification with deep residual networks in a mixed-cohort setting

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

STUDY OBJECTIVES: Parkinson's disease (PD) causes significant socioeconomic burdens. One of the strongest predictors of PD is rapid eye movement (REM) sleep behavior disorder (RBD; when there is no known other cause of RBD, referred to as idiopathic RBD [iRBD]), but there is no information about its factual welfare burden. We estimated the direct and indirect total costs of iRBD in a national sample of patients, based on a national register-based cohort study with matched controls.

METHODS: Using records from the Danish National Patient Registry, patient's diagnosis with RBD from 2006 to 2016 were identified. We excluded patients with a prior diagnosis of narcolepsy, PD, and other neurodegenerative diseases. We identified and compared randomly chosen controls matched for age, gender, geographic area, and civil status. Direct costs included frequencies of primary and secondary sector contacts and procedures, and medication. Indirect costs included the effect on labor supply. Social-transfer payments were included to illustrate the effect on national accounts.

RESULTS: A total of 246 iRBD patients and 982 matched controls were registered. iRBD patients had significantly higher rates of health-related contacts and of medication use, and higher socioeconomic costs than controls. The total additional direct net healthcare costs after the diagnosis (general practitioner services, hospital services, and medication) and indirect costs (loss of labor market income) was €13,088 for patients compared with controls. Patients already exhibited a negative social- and health-related status several years before the first diagnosis.

CONCLUSIONS: Diagnoses of iRBD have major socioeconomic consequences for patients, their partners, and society.

Original languageEnglish
JournalSleep (Online)
Volume44
Issue number2
ISSN1550-9109
DOIs
Publication statusPublished - 12 Feb 2021

ID: 61827224